The role of mitochondrial glutathione homeostasis in tumor formation

线粒体谷胱甘肽稳态在肿瘤形成中的作用

基本信息

  • 批准号:
    10660175
  • 负责人:
  • 金额:
    $ 50.21万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-04-01 至 2028-03-31
  • 项目状态:
    未结题

项目摘要

Project Summary Cancer cells require substantial antioxidant capacity to overcome toxic effects of reactive oxygen species (ROS). Despite their exclusive cytosolic production, cellular antioxidants are also abundantly present in organelles, particularly in mitochondria. In particular, mitochondria, as the source of reactive oxygen species (ROS), require substantial availability of antioxidants to protect its critical redox functions. While previous work suggests a link between mitochondrial redox metabolism and tumor growth, molecular mechanisms involved in maintaining mitochondrial redox homeostasis and the role of mitochondrial antioxidants in tumor progression are poorly understood. Among endogenous mitochondrial antioxidants, glutathione (GSH) is the dominant small molecule thiol, existing in millimolar concentrations. GSH is commonly upregulated in cancer cells, enabling metastatic colonization and resistance to chemotherapeutic drugs. In our previous work, using biochemical and proteomics methods, we identified SLC25A39, a mitochondrial membrane carrier of unknown function, to mediate GSH import into mitochondria of cancer cells. SLC25A39 loss strongly reduces mitochondrial GSH levels and its import, without impacting those in the cytosol. Our preliminary work suggests that SLC25A39 expression is associated with poor prognosis and decreased survival of breast cancer patients, and that SLC25A39 is necessary for breast cancer invasion and metastasis. This finding gave us the opportunity, for the first time, to uncouple mitochondrial redox metabolism from that of cytosol during tumor progression. Building upon this evidence, in this proposal, we will test the hypothesis that mitochondrial GSH import by SLC25A39 enables metastatic colonization of breast cancer cells. To address this, using biochemical and genetic experiments, we will first identify the precise mechanism by which mitochondrial GSH enables breast cancer cells to metastasize to lung. We will then test the role of mitochondrial GSH import by SLC25A39 in tumor formation and metastasis using mouse and human breast cancer models. Finally, SLC25A39 protein levels substantially increase during lung colonization, indicating a strong selective pressure to induce mitochondrial GSH uptake during metastasis. Therefore, we will determine how mitochondrial GSH availability and lung environment regulate SLC25A39 protein levels in breast cancer cells. This proposal will reveal the role of mitochondrial GSH homeostasis in breast cancer progression and will identify a compartmentalized sensing pathway essential for metastatic colonization.
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kivanc Birsoy其他文献

Kivanc Birsoy的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kivanc Birsoy', 18)}}的其他基金

Project 3: The role of microenvironmental metabolites on metastatic progression
项目3:微环境代谢物对转移进展的作用
  • 批准号:
    10271739
  • 财政年份:
    2021
  • 资助金额:
    $ 50.21万
  • 项目类别:
Project 3: The role of microenvironmental metabolites on metastatic progression
项目3:微环境代谢物对转移进展的作用
  • 批准号:
    10688117
  • 财政年份:
    2021
  • 资助金额:
    $ 50.21万
  • 项目类别:
Project 3: The role of microenvironmental metabolites on metastatic progression
项目3:微环境代谢物对转移进展的作用
  • 批准号:
    10493343
  • 财政年份:
    2021
  • 资助金额:
    $ 50.21万
  • 项目类别:
Single-Cell & Computational Biology Core
单细胞
  • 批准号:
    10688118
  • 财政年份:
    2021
  • 资助金额:
    $ 50.21万
  • 项目类别:
Identification of metabolic regulators of glycerolipid synthesis and storage
甘油脂合成和储存代谢调节剂的鉴定
  • 批准号:
    10682426
  • 财政年份:
    2019
  • 资助金额:
    $ 50.21万
  • 项目类别:
Identification of metabolic regulators of glycerolipid synthesis and storage
甘油脂合成和储存代谢调节剂的鉴定
  • 批准号:
    10220022
  • 财政年份:
    2019
  • 资助金额:
    $ 50.21万
  • 项目类别:
Identification of metabolic regulators of glycerolipid synthesis and storage
甘油脂合成和储存代谢调节剂的鉴定
  • 批准号:
    10017958
  • 财政年份:
    2019
  • 资助金额:
    $ 50.21万
  • 项目类别:
Identification of metabolic regulators of glycerolipid synthesis and storage
甘油脂合成和储存代谢调节剂的鉴定
  • 批准号:
    10456105
  • 财政年份:
    2019
  • 资助金额:
    $ 50.21万
  • 项目类别:
Metabolic liabilities of cancer cells to the tumor nutrient environment
癌细胞对肿瘤营养环境的代谢负担
  • 批准号:
    8868293
  • 财政年份:
    2016
  • 资助金额:
    $ 50.21万
  • 项目类别:
Metabolic liabilities of cancer cells to the tumor nutrient environment
癌细胞对肿瘤营养环境的代谢负担
  • 批准号:
    9414918
  • 财政年份:
    2016
  • 资助金额:
    $ 50.21万
  • 项目类别:

相似海外基金

Enhancing gamete cryoprotective properties of graphene oxide by dual functionalization with antioxidants and non-penetrating cryoprotectant molecules
通过抗氧化剂和非渗透性冷冻保护剂分子的双重功能化增强氧化石墨烯的配子冷冻保护特性
  • 批准号:
    24K18002
  • 财政年份:
    2024
  • 资助金额:
    $ 50.21万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
SBIR Phase I: Sustainable antioxidants for industrial process fluids
SBIR 第一阶段:工业过程流体的可持续抗氧化剂
  • 批准号:
    2222215
  • 财政年份:
    2023
  • 资助金额:
    $ 50.21万
  • 项目类别:
    Standard Grant
Development of a new bone augmentation method that enables long-term survival and long-term functional expression of transplanted cells by antioxidants
开发一种新的骨增强方法,通过抗氧化剂使移植细胞能够长期存活和长期功能表达
  • 批准号:
    23K09272
  • 财政年份:
    2023
  • 资助金额:
    $ 50.21万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Non-Invasive Probing Cellular Oxidative Stress and Antioxidants Therapeutic Effectiveness
非侵入性探测细胞氧化应激和抗氧化剂的治疗效果
  • 批准号:
    10652764
  • 财政年份:
    2023
  • 资助金额:
    $ 50.21万
  • 项目类别:
Mitochondria-targeting Novel Cationic Hydrazone Antioxidants for the Treatment of Preeclampsia
线粒体靶向新型阳离子腙抗氧化剂用于治疗先兆子痫
  • 批准号:
    10730652
  • 财政年份:
    2023
  • 资助金额:
    $ 50.21万
  • 项目类别:
Effects of different doses of antioxidants(Vitamin E) intake on exercise induced oxidative stress, antioxidative capacity and chronic inflammation
不同剂量抗氧化剂(维生素E)摄入对运动引起的氧化应激、抗氧化能力和慢性炎症的影响
  • 批准号:
    22K11609
  • 财政年份:
    2022
  • 资助金额:
    $ 50.21万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Contribution of antioxidants to regeneration of rotator cuff insertion
抗氧化剂对肩袖插入再生的贡献
  • 批准号:
    22K16720
  • 财政年份:
    2022
  • 资助金额:
    $ 50.21万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Latent Antioxidants for Environmentally Responsible Polymer Formulations
用于环保聚合物配方的潜在抗氧化剂
  • 批准号:
    RGPIN-2018-04107
  • 财政年份:
    2022
  • 资助金额:
    $ 50.21万
  • 项目类别:
    Discovery Grants Program - Individual
Polyunsaturated fatty acid (PUFA), inflammation and antioxidants
多不饱和脂肪酸 (PUFA)、炎症和抗氧化剂
  • 批准号:
    RGPIN-2019-05674
  • 财政年份:
    2022
  • 资助金额:
    $ 50.21万
  • 项目类别:
    Discovery Grants Program - Individual
Suppressed methemoglobin formation of artificial red cell by liposomal antioxidants and its mechanism.
脂质体抗氧化剂抑制人工红细胞高铁血红蛋白形成及其机制
  • 批准号:
    22K12824
  • 财政年份:
    2022
  • 资助金额:
    $ 50.21万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了